(Q40621225)

22 September 2017

Diagnosis and management of telaprevir-associated rash (English)

1 reference

22 September 2017

Eric J Lawitz

1

1 reference

22 September 2017

1 July 2011

1 reference

Gastroenterology & hepatology

22 September 2017

1 reference

22 September 2017

7

1 reference

22 September 2017

7

1 reference

22 September 2017

469-471

1 reference

Telaprevir for retreatment of HCV infection

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3264896

Telaprevir for previously untreated chronic hepatitis C virus infection

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3264896

Drug rash with eosinophilia and systemic symptoms due to telaprevir.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3264896

Telaprevir for previously treated chronic HCV infection

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3264896

The efficacy and safety of telaprevir - a new protease inhibitor against hepatitis C virus

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3264896

Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3264896

Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3264896

Telaprevir and peginterferon with or without ribavirin for chronic HCV infection

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3264896

Antiviral effects and safety of telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in hepatitis C patients

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3264896

20 August 2018

Identifiers

PMC publication ID

3264896

1 reference

PMC publication ID

3264896

22 September 2017

PubMed publication ID

22298982

1 reference

PMC publication ID

3264896